According to a new report, published by KBV research, The Global Veterinary Diagnostics Market size is expected to reach $15.6 billion by 2030, rising at a market growth of 10.4% CAGR during the forecast period.
The Instruments & Devices segment is showcasing a CAGR of 11.9% during (2023 - 2030). These instruments & devices are essential for diagnosing and monitoring the health of animals, whether they are companion animals, livestock, or wildlife. Advancements in veterinary diagnostics continue to improve the accuracy and speed of diagnosis, ultimately benefiting the well-being of animals and their healthcare.
The Laboratories segment is leading the Global Veterinary Diagnostics Market by End-use in 2022; thereby, achieving a market value of $5.6 billion by 2030. Veterinary laboratories offer various diagnostic tests, including blood tests, urinalysis, microbiology cultures, histopathology, and molecular diagnostics. These tests are essential for identifying pathogens, measuring specific biomarkers, and characterizing animal diseases. Laboratories play a crucial role in the early detection and surveillance of animal diseases. Timely diagnosis is essential for preventing the spread of contagious diseases, protecting animal populations, and safeguarding public health in zoonotic diseases.
The Infectious Diseases segment is experiencing a CAGR of 11.2% during (2023 - 2030). Veterinary diagnostics for infectious diseases are critical for early detection, prompt treatment, and implementing preventive measures such as vaccination and quarantine to control the spread of these diseases in animal populations. Advancements in diagnostic technologies continue to enhance the accuracy and speed of diagnosis in veterinary medicine, contributing to improved animal health and public health protection.
The Pathology segment acquired the highest revenue in the Global Veterinary Diagnostics Market by Testing Type in 2022; thereby, achieving a market value of $3.8 billion by 2030. Due to its vast range of services, including specialist diagnostics, imaging, and several lab tests. It consists of histopathology and immune histochemistry diagnostics used to detect alterations in animal tissues caused by a disease or medical condition. The cells can be extracted from animal biopsies, then processed and given to pathologists for evaluation using specialized staining techniques—Hematoxylin and Eosin (H&Es)—using sophisticated apparatus.
The Avian segment is exhibiting a CAGR of 11.7% during (2023 - 2030). Avian species veterinary diagnostics are crucial for maintaining the health and welfare of birds in various settings, including pets, commercial poultry production, wildlife conservation efforts, and captive breeding programs. Effective diagnostics help identify and manage diseases, optimize flock health, and contribute to responsible and ethical care for avian species. These diagnostics are essential for assessing, diagnosing, and monitoring health conditions in birds, whether they are kept as pets, raised for food production, or involved in wildlife conservation efforts.
The North America region dominated the Global Veterinary Diagnostics Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $6.2 billion by 2030. The Europe region is anticipated to grow at a CAGR of 10% during (2023 - 2030). Additionally, The Asia Pacific region would register a CAGR of 11.6% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/veterinary-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Heska Corporation (Antech Diagnostics, Inc), IDEXX Laboratories Inc., Agrolabo S.p.A., Innovative Diagnostics SAS (Idvet), Virbac, Thermo Fisher Scientific, Inc., Neogen Corporation, Covetrus, Inc. (Clayton, Dubilier & Rice, LLC), and iM3 Pty Ltd
By Product
By End Use
By Disease Type
By Testing Type
By Species
By Geography
Companies Profiled
Unique Offerings 
